Stock Report

Sanofi India posts net profit of Rs. 137.7 crores in Q4 CY2023

Posted On : 2024-02-23 23:15:46( TIMEZONE : IST )

Sanofi India Limited has reported Standalone financial results for the period ended December 31, 2023.

Financial Results (Q3 CY2023) - QoQ Comparison

The company has reported total income of Rs. 705.9 crores during the period ended December 31, 2023 as compared to Rs. 726.4 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs. 137.7 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 152.2 crores for the period ended June 30, 2023.

The company has reported EPS of Rs. 59.79 for the period ended December 31, 2023 as compared to Rs. 66.08 for the period ended June 30, 2023.

Financials	Q3 CY2023	Q2 CY2023	% Change
Total Income	₹ 705.9 crs	₹726.4 crs	-2.82%
Net Profit	₹137.7 crs	₹152.2 crs	-9.53%
EPS	₹59.79	₹66.08	-9.52%

Financial Results (Q3 CY2023) - YoY Comparison

The company has reported total income of Rs. 705.9 crores during the period ended December 31, 2023 as compared to Rs.691.9 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.137.7 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.130.9 crores for the period ended December 31, 2022.

The company has reported EPS of Rs.59.79 for the period ended December 31, 2023 as compared to Rs.56.84 for the period ended December 31, 2022.

Financials	Q3 CY2023	Q3 CY2022	% Change
Total Income	₹ 705.9 crs	₹691.9 crs	2.02%
Net Profit	₹137.7 crs	₹130.9 crs	5.19%
EPS	₹59.79	₹56.84	5.19%

Financial Results (9 Months Ended CY2023) - YoY Comparison

The company has reported total income of Rs.2916.4 crores during the 9 Months period ended December 31, 2023 as compared to Rs.2841.6 crores during the 9 Months period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.603.2 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.620.6 crores for the 9 Months period ended December 31, 2022.

The company has reported EPS of Rs.261.91 for the 9 Months period ended December 31, 2023 as compared to Rs.269.47 for the 9 Months period ended December 31, 2022.

Financials	9 Months Ended CY2023	9 Months Ended CY2022	% Change
Total Income	₹2916.4 crs	₹2841.6 crs	2.63%
Net Profit	₹603.2 crs	₹620.6 crs	-2.80%
EPS	₹261.91	₹269.47	-2.81%

Shares of Sanofi India Limited was last trading in BSE at Rs. 9132.75 as compared to the previous close of Rs. 9212.40. The total number of shares traded during the day was 1322 in over 586 trades.

The stock hit an intraday high of Rs. 9370.35 and intraday low of 9100.10. The net turnover during the day was Rs. 12241591.00.